Medicus Pharma Ltd. (MDCX) Institutional Ownership

Ownership Summary

The institutional landscape for Medicus Pharma Ltd. (NASDAQ:MDCX) includes 21 filers as of the latest reporting cycle ending December 2025.

• Medicus Pharma saw its institutional ownership percentage rose to 24.6% in December 2025 from 13.4% in September 2025.
• In percentage terms, this reflects as a holdings change of 109.18% quarter on quarter, and an increase of 425.00% year over year.
• During the quarter, 13 institutions bought more Medicus Pharma shares, 1 sold shares, and 7 of the 21 total investors held their position steady.
• This class of investors increased its holdings in Medicus Pharma to 3.94Mn shares for the 13F-cycle ending December 2025, up by 2.06Mn shares quarter on quarter, and up 2.44Mn shares year over year.
• ARMISTICE CAPITAL, LLC continues to be the largest institutional holder of Medicus Pharma as of December 31, 2025, with a position of 1.81Mn shares, representing 11.29% of the company's outstanding stock.
• Among the most significant buyers of Medicus Pharma during December 2025 were ARMISTICE CAPITAL, LLC (1.81Mn), JANE STREET GROUP, LLC (60.34K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (40.16K), HRT FINANCIAL LP (27.53K), Private Advisor Group, LLC (24.00K).
• Leading sellers of Medicus Pharma stock in December 2025 included OSAIC HOLDINGS, INC. (5.50K).
• The top 10 institutional holders of Medicus Pharma for the quarter ending December 2025 included ARMISTICE CAPITAL, LLC (1.81Mn), Interchange Capital Partners, LLC (1.59Mn), Private Advisor Group, LLC (175.50K), JANE STREET GROUP, LLC (60.34K), Wilmington Savings Fund Society, FSB (51.24K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (40.16K), May Hill Capital, LLC (35.62K), BlackRock, Inc. (34.32K), COMMONWEALTH EQUITY SERVICES, LLC (28.49K), HRT FINANCIAL LP (27.53K).